| 英文名称 | | 中文名称 | | CAS |
---|---|---|
GZD824 | GZD824DIMESYLATE | 1421783-64-3 |
JNK-IN-8 | JNK-IN-8 | 1410880-22-6 |
Tazemetostat (EPZ-6438) | EPZ-6438 | 1403254-99-8 |
GSK2879552 | GSK2879552 | 1401966-69-5 |
BIX 01294 | BIX 01294三盐酸盐水合物 | 1392399-03-9 |
JD-5037 | JD-5037 | 1392116-14-1 |
Umibecestat | Umibecestat | 1387560-01-1 |
8-benzyl-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one | Furimazine | 1374040-24-0 |
Ubrogepant | 乌布吉泮 | 1374248-77-7 |
TUG 891 | TUG 891 | 1374516-07-0 |
GSK2636771 | GSK2636771 | 1372540-25-4 |
X-376 | 恩沙替尼 | 1365267-27-1 |
ALK/IGF1R inhibitor | AZD3463 | 1356962-20-3 |
EW-7197 | EW-7197 | 1352608-82-2 |
S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide | GSK126 | 1346574-57-9 |
ERDAFITINIB | 厄达替尼 | 1346242-81-6 |
INCB8761(PF-4136309) | INCB8761(PF-4136309) | 1341224-83-6 |
MKC8866 | MKC8866 | 1338934-59-0 |
CFI-400945 | 1338806-73-7 | 1338806-73-7 |
N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide | BMS-3 | 1338247-30-5 |